Excessive Differentiation of Myeloid Cells in AML-M2 with Translocation 8;21
t(8;21) is a chromosomal abnormality found in a part of AML-M2 cases and exceptionally in other blood disorders. According to literature data, CR in this form of M2 is easy to obtain and therefore BMT is not recommended in the first remission. We report here on 3 patients observed in the past 3 years, in whom blood disease was firstly diagnosed as blast crisis/acceleration of CML, because of an excessive differentiation of their leukemic cells and low FAG scores. These results prompted us to diagnose BC/ACC-CML and to administer a proper therapy. However, cytogenetic examination of BM cells of the patients did not confirm the diagnosis: t(8;21) and no Ph chromosome was found in all samples examined, which enabled us to change the diagnosis. During the course of the disease a disappea-rance of t(8;21) in remissions and reappearance in relapses was revealed. t(8;21) is very rarely seen in BC-CML of M2 type and was never described in Ph(-) CML. Our observation confirm that of Yamasaki and co. that t(8;21) M2 may show an excessive differentiation of the myeloid cell line.
KeywordsLeukemia Pneumonia Anemia Oncol Sarcoma
Unable to display preview. Download preview PDF.
- 8.Fenaux P, Lai JL, Preudhomme C, Jouet JP, Deminatti H, Bauters F (1990) Is translocation (8;21) a “favourable” cytogenetic rearrangement in acute myeloid leukemia ? Nouv Rev Hematol, 32: 179–182Google Scholar
- 10.Tallman MS, Hakimian D, Shaw JM, Lissner GS, Russell EJ,Variakojis D (1993) Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol, 11, 690–697Google Scholar
- 18.ISCN (1991) Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. Mitelman E(ed); S.Karger, BaselGoogle Scholar
- 19.ISCN (1995) An International System for Human Cytogenetic Nomenclature. Mitelman F. (ed); S. Karger, BaselGoogle Scholar